Peptide Purity & Quality.

Peptide quality is the single most important variable that most consumers underestimate. A peptide purchased from a reputable source with verified purity is a fundamentally different product from one bought based on price alone from an unverified supplier. Understanding how quality is measured, what to look for, and what red flags to avoid can mean the difference between a product that works as expected and one that is contaminated, underdosed, or misidentified. Purity testing relies on two primary analytical techniques. High-Performance Liquid Chromatography (HPLC) separates the components of a sample and measures the percentage of the target peptide versus impurities. A single peak at the correct retention time indicates a pure sample. Purity is expressed as a percentage: greater than 98% is considered pharmaceutical grade, greater than 95% is acceptable research grade, and below 95% is questionable for any application. The remaining percentage consists of synthesis byproducts (truncated sequences, deletion sequences, racemized amino acids), residual solvents from manufacturing, and unrelated contaminants. Mass spectrometry (MS) confirms molecular identity — it measures the molecular weight of the compound to verify it matches the expected peptide. HPLC and MS are complementary: HPLC tells you how pure it is, MS tells you what it is. A legitimate Certificate of Analysis should include both. For injectable peptides, endotoxin testing is critical. Bacterial endotoxins (lipopolysaccharides from gram-negative bacteria) can cause fever, inflammation, and in severe cases, septic shock when injected. The Limulus Amebocyte Lysate (LAL) test detects endotoxins. Any peptide intended for injection should have endotoxin levels below 5 EU/kg body weight per dose. Not all sellers test for endotoxins, and this omission is a significant quality gap. Certificates of Analysis (COAs) are the primary quality documentation. A legitimate COA should include the peptide name and batch/lot number, HPLC chromatogram showing a clear primary peak with purity percentage, mass spectrometry data confirming molecular weight matches the target peptide, endotoxin results for injectables, the testing date and laboratory name, and a batch-specific reference (not a generic template). Red flags in COAs include missing batch numbers, round purity numbers (exactly 99.00% is suspicious — real measurements have decimal variation), absence of the actual chromatogram (just a number without the graph), testing dates that do not match the batch production date, and generic COAs that appear identical across different products or batches. The current regulatory environment has shifted substantially. The FDA has increased enforcement against companies selling unapproved peptides for human use. In 2023 and 2024, the FDA issued warning letters, seizure orders, and injunctions against peptide companies and compounding pharmacies. Some peptides (including BPC-157) were placed on the FDA's "difficult to compound" list, restricting their availability through compounding pharmacies. Research chemical companies operate in a gray area — selling peptides labeled "for research purposes only, not for human consumption." The legal landscape varies by country: some jurisdictions regulate peptides as pharmaceuticals, others as research chemicals, and some have minimal regulation. Evaluating sources requires skepticism and due diligence. Third-party testing by independent labs (not the seller's own lab) provides the strongest assurance. Sellers who publish COAs for every batch, who respond to quality inquiries transparently, and who have a track record in the community offer lower risk than anonymous sellers with no testing documentation. Price can be a signal: if a peptide is dramatically cheaper than the market norm, the savings may come from lower purity, reduced testing, or inferior synthesis methods. However, the most expensive option is not automatically the best — marketing budgets do not equal quality control budgets. Learning to read a COA is a valuable skill. The HPLC chromatogram should show a single dominant peak — multiple significant peaks indicate impurities. The mass spectrum should show a peak at the expected molecular weight of the peptide. The purity percentage, molecular weight match, and endotoxin results together tell you whether a product is what it claims to be, how pure it is, and whether it is safe for injection. If a seller cannot or will not provide this documentation, that is the most significant red flag of all.